Across TCGA pan-cancer cohorts, SCAT8 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated SCAT8 data layer.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SCAT8 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SCAT8 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUSC show a favorable association.
HNSC, KIRC, and BLCA are the cancer types where SCAT8 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.